On the other hand, mutations in the CDKN2A gene are mainly associated with an elevated risk of oncological conditions, such as melanoma and pancreatic cancer [12], entities identified through specific genetic tests in about 38% of families with melanoma history [13]. Here, CDKN2A is linked to melanoma.